Clinical Trial Update: Immune Regulation in Multiple Sclerosis: The Effect of Glatiramer Acetate on MicroRNA Expression in Antigen-Presenting Cells

View source ↗

Summary

The clinical trial has completed. It evaluated the effect of glatiramer acetate on microRNA expression in antigen-presenting cells in multiple sclerosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Drugs mentioned

• GLATIRAMER ACETATE (GLATIRAMER ACETATE)

Snippet

Sponsor: Rutgers, The State University of New Jersey | Conditions: Multiple Sclerosis | Status: COMPLETED